XORTX outlines Health Canada CTA for XRx-026
- Planned CTA submission to Health Canada for XRx-026 gout program
- XRX-OXY-102 clinical study to evaluate XORLO for gout treatment
- First part of study to be conducted in Canada to accelerate FDA NDA filing
XRTX
XORTX Therapeutics Inc. SEC filings
Every EDGAR filing for XORTX Therapeutics Inc. (XRTX), newest first, with AI summaries and stories.
- Ticker
- XRTX
- CIK
- 1729214
- Latest filing
- Oct 8
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINE424B4XORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINEEFFECTXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINEPOS AMXORTX Therapeutics Inc.XRTXLIVE ROUTINEPOS AMXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE NOTABLE20-FXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.XRTXLIVE ROUTINE6-KXORTX Therapeutics Inc.LIVE